Testosterone and biological characteristics of breast cancers in postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 11, 2009, Pages 2942-2948

  Secreto, Giorgio ^a   Venturelli, Elisabetta ^a   Meneghini, Elisabetta ^a   Greco, Marco ^a   Ferraris, Cristina ^a   Gion, Massimo ^b   Zancan, Matelda ^b   Fabricio, Aline S C ^b   Berrino, Franco ^a   Cavalleri, Adalberto ^a   Micheli, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Regional Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TESTOSTERONE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FISHER EXACT TEST; HISTOLOGY; HUMAN; INTRADUCTAL CARCINOMA; KRUSKAL WALLIS TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TESTOSTERONE BLOOD LEVEL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AGING; AXILLA; BODY MASS INDEX; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; POSTMENOPAUSE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TESTOSTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 72749102007     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0540     Document Type: Article

References (34)

1. Secreto G, Venturelli E, Pasanisi P, Berrino F. Androgens and breast cancer. The hyperandrogenic theory of breast cancer: past, present and future. In: Ardis LI, editor. Testosterone research trends. New York: Nova Science Publishers, Inc.; 2007. p. 105-138
2. Key T, Appleby P, Barnes I, Reeves G; The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausalwomen: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-616
3. Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-1082 (Pubitemid 41815798)
4. Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J NatlCancer Inst 2005;97:755-765 (Pubitemid 40879595)
5. Micheli A, Muti P, Secreto G, et al. Endogenous sex hormones and subsequent breast cancer in premenopausalwomen. Int J Cancer 2004;112:312-318 (Pubitemid 39244371)
6. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24:152-182 (Pubitemid 36515283)
7. Dimitrakakis C, Zhou J, Bondy CA. Androgens and mammary growth and neoplasia. Fertil Steril 2002;77:S26-33.
8. Dimitrakakis C, Zhou J, Wang J, et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2003;10:292-298 (Pubitemid 36870501)
9. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K, Bondy CA. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 2000;14:1725-1730 (Pubitemid 30688622)
10. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
11. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:645-651 (Pubitemid 32273648)
12. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853 (Pubitemid 41058142)
13. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004;111:762-771 (Pubitemid 39062901)
14. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol2000;152:514-527
15. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectionalstudy in healthy women. Eur J Endocrinol 2004;150:161-171
16. McTiernan A, Wu L, Chen C, et al; Women's Health Initiative Investigators. Relation of BMI and physical activity to sex hormones in postmenopausalwomen. Obesity (Silver Spring) 2006;14:1662-1677
17. Key TJ, Appleby PN, Reeves GK, et al; Endogenous Hormones Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-1226
18. Rinaldi S, Key TJ, Peeters PH, et al. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer 2006;118:2832-2839
19. Asseryanis E, Ruecklinger E, Hellan M, Kubista E, Singer CF. Breast cancer size in postmenopausalwomen is correlated with body mass index and androgen serum levels. Gynecol Endocrinol 2004;18:29-36. (Pubitemid 38134761)
20. Berclaz G, Li S, Price KN, et al; International Breast Cancer Study Group. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004;15:875-884
21. Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. Cancer EpidemiolBiomarkers Prev 2005;14:1047-1051 (Pubitemid 40656446)
22. Sieri S, Krogh V, Bolelli G, et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDETcohort. Cancer Epidemiol Biomarkers Prev 2009;18:169-176
23. Kahán Z, Gardi J, Nyári T, et al. Elevated levels of circulating insulinlike growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausalwomen: a casecontrolstudy . Int J Oncol 2006;29:193-200.
24. Grattarola R. Ovariectomy alone or in combination with dexamethasone in patients with advanced breast cancer and high levels of testosterone excretion. J NatlCancer Inst 1976;56:11-16
25. Secreto G, Zumoff B. Paradoxicaleffects associated with supranormal urinary testosterone excretion in premenopausalwomen with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy. Cancer Res 1983;43:3408-3411
26. Secreto G, Oriana S, Recchione C. Ovariectomy alone or in combination with dexamethasone in patients with advanced breast cancer and high levels of testosterone or androstanediol secretion. Endocr Relat Cancer 1984;14:55-58
27. Oriana S, Secreto G, Di Fronzo G, Torri A. Urinary androgens and tumor estrogen receptor as predictors of oophorectomy response and of survivali n advanced breast cancer. Breast Cancer Res Treat 1987;9:201-205 (Pubitemid 17129957)
28. Ballerini P, Oriana S, Duca P, et al. Urinary testosterone as a marker of risk of recurrence in operable breast cancer. Breast Cancer Res Treat 1993;26:1-6. (Pubitemid 23249111)
29. Berrino F, Pasanisi P, Bellati C, et al. Serum testosterone levels and breast cancer recurrence. Int J Cancer 2005;113:499-502. (Pubitemid 40038721)
30. Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE, Jr. Serum sex hormones and breast cancer risk factors in postmenopausalwom en. Cancer Epidemiol Biomarkers Prev 2003;12:380-383
31. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832-2838 (Pubitemid 32269161)
32. Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausalwomen. J Clin Endocrinol Metab 2007;92:3040-3043
33. Sommers SC, Teloh HA. Ovarian stromal hyperplasia in breast cancer. Arch Pathol1952;53:160-168
34. Berger R, Lin DI, Nieto M, et al. Androgen-dependent regulation of Her-2/neu in prostate cancer cells. Cancer Res 2006;66:5723-5728 (Pubitemid 43927125)